Fund. (2) Trade and other accounts receivable increased THB 276.30 million or 36.53%. This is in accordance with the increase of the revenue of the Company. Moreover, the balance of trade accounts
) Public Company Limited ( the “Company”) would like to clarify its operation results for the Quarter1/FY2020 ( ended December 31st, 2019) of the Company and its subsidiaries, as follows: (unit: million baht
Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited and its subsidiaries (the “Company”) would like to clarify on the operating results for the first quarter
WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED No. WPH – SET 2/2017 2 October 2017 Subject : Management Discussion and Analysis for the year ended on December 31, 2016 To : Directors and Manager The Stock
/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
as at and 30th September 2020 and 31st March 2020, the company and subsidiaries had total assets of 1,962.02 million baht and 2,118.54 million baht respectively, with short term investments, trade
Company had D/E ratio 0.11 times, decreased from 2016 that had 0.16 times, as a result of trade account payable and other payables decreased. Return on Equity (ROE) The 42.91 million Baht net profit is 4.85
30, 2022, the Company’ s total liabilities decreased by 70. 6 MB or 2. 6% from December 31, 2021, the reasons for major changes are as follows: Trade and other payables increased by 194. 8 MB
Public Company Limited’s (the “Company”) Board of Directors Meeting No. 4/2024 held on 9 August 2024 passed a resolution to certify the financial statements and the performance for the six-month period
Hub Public Company Limited’s (the “Company”) Board of Directors Meeting No. 5/2024 held on 12 November 2024 passed a resolution to certify the financial statements and the performance for the nine-month